Esperion Therapeutics Inc. (ESPR) Gained 5.9% or 4.11 To Price $73.82 On Wednesday


Esperion Therapeutics Inc. (ESPR) gained 5.9% or 4.11 to $73.82. It is approximately 592813 shares traded, which is 87.04% compare to the average total volume 681077. The market cap of ESPR is $1.96 billion. The year to date change is 4.83%. The 52 week price range is from $30.95 to $82.68. Price of ESPR have changed -1.39% during last week. It have changed -12.92% over last month, -0.29% over last 3 months, 22.66% over last 6 months and 84.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ESPR is 73.32. It is -0.68% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for ESPR is 58.21. It is -21.15% below current price. The 52-week High is 82.68. It is 12.00% from the current price. The 52-week Low is 30.95. It is -58.07% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ESPR is 4.05 on 2018-03-15. Short % to float is 11.22%. There are some statistics of ESPR. It is has market cap $1.96 billion. The share outstanding is 26.50 million. The average volume is 681077. It has 752.86M cash and 6.75M in debt. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ESPR is -70.56%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ESPR is -63.85%.


Tags:

Share this post